Teva acquires Emalex Biosciences for up to $900m
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) today announced it has signed a definitive agreement to acquire Emalex ...
Saturday, May 30, 2026
Tag: Biosciences
Twist Biosciences: Keeping Synthetic Biology Alive
Remember synthetic biology? It was a technology platform that would allow mankind to play God. Not long after Craig Venter ...
JPMorgan Raises Cogent Biosciences (COGT) PT to $67 on Sector Model Update
Cogent Biosciences Inc. (NASDAQ:COGT) is one of the best emerging technology stocks to invest in. On December 19, JPMorgan raised ...
Spruce Biosciences – SPRB: Citizens stuft auf „Market Outperform“ hoch!
Einlizenzierung von TA-ERT! Bis zu 170 Mio. Umsatz p.a.! Spruce Biosciences (SPRB) will Zulassungsantrag im I. Quartal 2026 einreichen. Spruce ...
Genflow Biosciences announces second European patent application (GENFF:OTCMKTS)
Genflow Biosciences (OTCQB:GENFF) on Wednesday announced that its second European patent application (Application No. 23821586.7, Publication No. EP4630038), titled "SIRT6 ...
Avidity Biosciences reports data from DMD treatment trials
Avidity Biosciences (NASDAQ:RNA) has announced new data from its clinical trials evaluating the experimental treatment del-zota for Duchenne muscular dystrophy. ...
The first and only national digital and print magazine that connects individuals, families, and businesses to Fee-Only financial advisers, accountants, attorneys and college guidance counselors.